一个基于复制品的COVID-19疫苗候选人,由烟草马赛克病毒样粒子传递

Sweta Karan1, Patrick Opdensteinen1, Yifeng Ma1

  • 1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, University of California, San Diego, La Jolla, CA 92093, USA; Shu and K.C. Chien and Peter Farrell Collaboratory, University of California, San Diego, La Jolla, CA, USA; Center for Nano-ImmunoEngineering, University of California, San Diego, La Jolla, CA, United States.

Vaccine
|April 1, 2025
PubMed
概括

一个基于新型烟草马赛克病毒 (TMV) 的平台为传染病提供mRNA疫苗. 这种纳米技术能够在植物中快速适应和潜在生产,提供稳定,可访问的疫苗解决方案.